Uniphar (UPR.I, UPR ID)

  • 679.8
  • 273.0
  • 86.6

    Closing Price (c): 249.0

  • RATING 27/08/19


Company Profile

Uniphar is a diversified healthcare services business operating across three divisions: Commercial & Clinical (47% of group EBITDA 2022E), Product Access (19%) and Supply Chain & Retail (34%). Structural industry growth, proprietary digital platforms and expansion into new geographies underpin a strong organic growth outlook. There is also meaningful scope for bolt-on M&A, supported by a senior leadership team with deep experience across the healthcare services space. Management aims to double group EBITDA within five years (15% CAGR).

Major Shareholders%
Allianz Global Investors12.0
Polar Capital LLP7.4
Mackenzie Financial Corp.6.4
Sisk Family5.9
ROI HealthCo IOM 1 Ltd.4.6